UPDATE: Jefferies Raises PT on Agilent Technologies Following 3Q13 EPS Report
UPDATE: Jefferies Raises PT on EXACT Sciences Following Proprietary Physician Survey
UPDATE: Jefferies Assumes Coverage on Luminex at Hold on Long-Term Caution
UPDATE: Jefferies Assumes Coverage on Genomic Health at Hold Awaiting Profitability
Brandon Couillard Recent News
UPDATE: Jefferies Assumes Coverage on Sequenom at Buy on Unappreciated Value
UPDATE: Jefferies Assumes Coverage on OraSure Technologies at Buy on Weaker Demand Trend Concerns
UPDATE: Jefferies Assumes Coverage on Nanosphere at Buy Awaiting Gram-Positive Ramp
UPDATE: Jefferies Assumes Coverage on EXACT Sciences with Buy on Increased Confidence
UPDATE: Jefferies Assumes Coverage on Myriad Genetics, Downgrades to Hold Ahead of SCOTUS Decision
UPDATE: Jefferies Assumes Coverage on Cepheid, Downgrades to Hold on Valuation
UPDATE: Jefferies Downgrades Cepheid to Hold on Persistent Volatility
UPDATE: Jefferies Downgrades Align Technology to Hold, Raises PT on Balanced Risk/Reward
Jeffries & Company Maintains Pall (PLL) Buy Rating